Pharmaceuticals in India
Description
Pharmaceuticals in India
Summary
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The Indian pharmaceuticals market recorded revenues of $40.3 billion in 2024, representing a compound annual growth rate (CAGR) of 4.9% between 2019 and 2024.
- The anti-infective drugs segment accounted for the market's largest proportion in 2024, with total revenues of $3.5 billion, equivalent to 8.6% of the market's overall value.
- The Indian pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 6.1%.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the India pharmaceuticals market by value in 2024?
- What will be the size of the India pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the India pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in India's pharmaceuticals market?
Table of Contents
44 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of the leading players?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Sun Pharmaceutical Industries Ltd
- 8.2. Lupin Ltd
- 8.3. Cipla Ltd
- 8.4. Dr. Reddy's Laboratories Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: India pharmaceuticals market value: $ million, 2019-24
- Table 2: India pharmaceuticals market category segmentation: % share, by value, 2019-24
- Table 3: India pharmaceuticals market category segmentation: $ million, 2019-24
- Table 4: India pharmaceuticals market geography segmentation: $ million, 2024
- Table 5: India pharmaceuticals market value forecast: $ million, 2024-29
- Table 6: Sun Pharmaceutical Industries Ltd: Key Facts
- Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
- Table 9: Lupin Ltd: Key Facts
- Table 10: Lupin Ltd: Annual Financial Ratios
- Table 11: Lupin Ltd: Key Employees
- Table 12: Cipla Ltd: Key Facts
- Table 13: Cipla Ltd: Annual Financial Ratios
- Table 14: Cipla Ltd: Key Employees
- Table 15: Dr. Reddy's Laboratories Ltd: Key Facts
- Table 16: Dr. Reddy's Laboratories Ltd: Annual Financial Ratios
- Table 17: Dr. Reddy's Laboratories Ltd: Key Employees
- Table 18: India Size of Population (Million), 2020-24
- Table 19: India Real GDP (Constant 2010 Prices, $ Billion), 2020-24
- Table 20: India GDP (Current Prices, $ Billion), 2020-24
- Table 21: India Inflation, 2020-24
- Table 22: India Consumer Price Index (Absolute), 2020-24
- Table 23: India Exchange Rate, 2019-24
- List of Figures
- Figure 1: India pharmaceuticals market value: $ million, 2019-24
- Figure 2: India pharmaceuticals market category segmentation: $ million, 2019-24
- Figure 3: India pharmaceuticals market geography segmentation: % share, by value, 2024
- Figure 4: India pharmaceuticals market value forecast: $ million, 2024-29
- Figure 5: Forces driving competition in the pharmaceuticals market in India, 2024
- Figure 6: Drivers of buyer power in the pharmaceuticals market in India, 2024
- Figure 7: Drivers of supplier power in the pharmaceuticals market in India, 2024
- Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2024
- Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2024
- Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in India, 2024
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
